251 related articles for article (PubMed ID: 6715512)
1. Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters.
Jahrling PB; Stephenson EH
J Clin Microbiol; 1984 Mar; 19(3):429-31. PubMed ID: 6715512
[TBL] [Abstract][Full Text] [Related]
2. Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates.
Pratt WD; Gibbs P; Pitt ML; Schmaljohn AL
Vaccine; 1998; 16(9-10):1056-64. PubMed ID: 9682359
[TBL] [Abstract][Full Text] [Related]
3. 1,5-Iodonaphthyl azide-inactivated V3526 protects against aerosol challenge with virulent venezuelan equine encephalitis virus.
Gupta P; Sharma A; Spurgers KB; Bakken RR; Eccleston LT; Cohen JW; Honnold SP; Glass PJ; Maheshwari RK
Vaccine; 2016 May; 34(25):2762-5. PubMed ID: 27129427
[TBL] [Abstract][Full Text] [Related]
4. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.
Reed DS; Lind CM; Lackemeyer MG; Sullivan LJ; Pratt WD; Parker MD
Vaccine; 2005 May; 23(24):3139-47. PubMed ID: 15837213
[TBL] [Abstract][Full Text] [Related]
5. Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice.
Hart MK; Pratt W; Panelo F; Tammariello R; Dertzbaugh M
Vaccine; 1997 Mar; 15(4):363-9. PubMed ID: 9141206
[TBL] [Abstract][Full Text] [Related]
6. [The protective activity of the attenuated strain 15 of the Venezuelan equine encephalomyelitis virus in rodent infection via the respiratory tract].
Filatenkov AG; Khaltaeva GG; Khlebnikova NN; Gorban' SG; Shkurnikova NN; Khamitova MF
Vopr Virusol; 1991; 36(3):229-31. PubMed ID: 1891877
[TBL] [Abstract][Full Text] [Related]
7. Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge.
Kinney RM; Esposito JJ; Mathews JH; Johnson BJ; Roehrig JT; Barrett AD; Trent DW
J Virol; 1988 Dec; 62(12):4697-702. PubMed ID: 3184276
[TBL] [Abstract][Full Text] [Related]
8. Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine.
Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM
Vaccine; 1998 Aug; 16(13):1314-23. PubMed ID: 9682396
[TBL] [Abstract][Full Text] [Related]
9. A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge.
Henning L; Endt K; Steigerwald R; Anderson M; Volkmann A
Front Immunol; 2020; 11():598847. PubMed ID: 33542715
[TBL] [Abstract][Full Text] [Related]
10. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate.
Hart MK; Caswell-Stephan K; Bakken R; Tammariello R; Pratt W; Davis N; Johnston RE; Smith J; Steele K
Vaccine; 2000 Jul; 18(26):3067-75. PubMed ID: 10825611
[TBL] [Abstract][Full Text] [Related]
11. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA
Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002
[TBL] [Abstract][Full Text] [Related]
12. Early protection in hamsters immunized with attenuated Venezuelan equine encephalomyelitis vaccine.
Cole FE; Pedersen CE; Robinson DM
Appl Microbiol; 1972 Oct; 24(4):604-8. PubMed ID: 5086903
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of protective immune responses to Venezuelan equine encephalitis (VEE) virus with microencapsulated vaccine.
Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM
Vaccine; 1995; 13(15):1411-20. PubMed ID: 8578818
[TBL] [Abstract][Full Text] [Related]
14. Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine.
Tretyakova I; Lukashevich IS; Glass P; Wang E; Weaver S; Pushko P
Vaccine; 2013 Feb; 31(7):1019-25. PubMed ID: 23287629
[TBL] [Abstract][Full Text] [Related]
15. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.
Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I
J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus.
Martin SS; Bakken RR; Lind CM; Garcia P; Jenkins E; Glass PJ; Parker MD; Hart MK; Fine DL
Vaccine; 2010 Apr; 28(18):3143-51. PubMed ID: 20193792
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB.
Martin SS; Bakken RR; Lind CM; Garcia P; Jenkins E; Glass PJ; Parker MD; Hart MK; Fine DL
Vaccine; 2010 Jan; 28(4):1031-40. PubMed ID: 19914193
[TBL] [Abstract][Full Text] [Related]
18. IRES-Containing VEEV Vaccine Protects Cynomolgus Macaques from IE Venezuelan Equine Encephalitis Virus Aerosol Challenge.
Rossi SL; Russell-Lodrigue KE; Killeen SZ; Wang E; Leal G; Bergren NA; Vinet-Oliphant H; Weaver SC; Roy CJ
PLoS Negl Trop Dis; 2015 May; 9(5):e0003797. PubMed ID: 26020513
[TBL] [Abstract][Full Text] [Related]
19. A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates.
Dupuy LC; Richards MJ; Ellefsen B; Chau L; Luxembourg A; Hannaman D; Livingston BD; Schmaljohn CS
Clin Vaccine Immunol; 2011 May; 18(5):707-16. PubMed ID: 21450977
[TBL] [Abstract][Full Text] [Related]
20. Venezuelan equine encephalitis vaccine with rearranged genome resists reversion and protects non-human primates from viremia after aerosol challenge.
Tretyakova I; Plante KS; Rossi SL; Lawrence WS; Peel JE; Gudjohnsen S; Wang E; Mirchandani D; Tibbens A; Lamichhane TN; Lukashevich IS; Comer JE; Weaver SC; Pushko P
Vaccine; 2020 Apr; 38(17):3378-3386. PubMed ID: 32085953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
